Chronopharmacokinetics of acetaminophen in healthy human volunteers

  • Kolawole J. A. 
  • Chuhwak P. D. 
  • Okeniyi S. O. 


Acetaminophen is a common antipyretic-analgesic drug usually administered orally any time of the day. It was however claimed by Belanger et al, (1985) to have a longer elimination half-life (t1/2β) in rats when administered by 2100 h, than at 0700 h. This work is designed to investigate this claim in man and to study the circadian changes in acetaminophen pharmacokinetics at three dosing times; 0730 h, 1300 h and 2100 h. Seven healthy male volunteers, age 26.28±3.01 years, weighing 65.00±2.2 kg, were administered with 1000 mg oral acetaminophen at the three circadian time after a period of fast of not less than 4 h. The pharmacokinetic values obtained, though varied, are found to be in similar ranges with previously reported values. The absorption parameters ka and mean Tmax were significantly altered with dosing at 0730 h and 2100 h while the mean t1/2α and ka were also significantly changed. There was a significant difference (P<0.05) between the Tmax values obtained at 2100 h and that of 0730 h, while the 34.9% increase at dosing time 1300 h over 0730 h dosing times is not statistically significant (P>0.05). Cmax was found to be 22.31±4.24 mcg/ml for 0730h dosing time, while a decrease of 9.64 and 11.7% over this value was recorded for dosing time 1300 h and 2100 h respectively. The changes are however not statistically significant (P>0.05). AUCo−a at 0730 h did not show any significant change when compared with values obtained at 1300 h and 2100 h, but there was a significant difference between the values obtained at 1300 h and 2100 h. Elimination half-life, t1/2β was found to be 1.68±0.67 h at 0730 h. There was an increase of 13.1% and 20.83% over this value at 1300 h and 2100 h. These increases were not statistically significant (p>0.05). Although there are similar increases in t1/2β at the 1300 h and 2100 h dosing time as reported by Belanger et al 1985, the increases were not statistically significant in man.


Chronopharmacokinetics acetaminophen pharmacokinetics 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Shamba E and Adotey J. (1982)._- pharmacy/pubs/1982.html.Google Scholar
  2. 2.
    The Pharmaceutical Codex (1979): 11th Ed. 1979, The Pharmaceutical Press, 1 Lambeth High Street, London SEI JN USA.Google Scholar
  3. 3.
    Bruguerolle B. (1998): Chronopharmacokinetics. Current Status. [Review]. Clin. Pharmacokinet. 35(4); 83–94.CrossRefPubMedGoogle Scholar
  4. 4.
    Markiewicz A. and Semenowicz K. (1979): Circadian changes in intestinal absorption. Chronobiologia (Milan), 6, 129.Google Scholar
  5. 5.
    Valli-M, Bruguerolle B, Bouyard L, Jadot G. and Bouyard P. (1980): Pharmacokinetics of Carbamazepine in fasted and fed rats. J. Pharmacol 11, 201.Google Scholar
  6. 6.
    Kabasakalian P. Katz M., Rosenkrantz and Towley E (1970): ‘Chronokinetics of griseofulvin after a high-fat meal in human volunteers at breakfast and at dinner’. J. Pharm Sci. 59, 595.CrossRefPubMedGoogle Scholar
  7. 7.
    Brugueroll B, Levi F, Arnaud C, Bouvenot G, Mechkouri M, Vennetzel J. M. and Touitou T. (1986): Annu. Rev. Chronopharmacol. 3, 207.Google Scholar
  8. 8.
    Naranjo C. A. Seller E. M. Giles H. G. and Abel J. G. B. (1980): ‘Diurnal changes of diazepam concentration in the serum’. Br. J. Clin. Pharmacol. 9, 265.PubMedGoogle Scholar
  9. 9.
    Patel I. H. Venkatavannan R., Levy R. H., Viswanathorn R. H and Ojemann L M. (1982): ‘Plasma protein characteristics of valprotic acid in humans’. Epilepsia (NY) 23, 282.Google Scholar
  10. 10.
    Radzialower G. and Bonsquet, W. F. (1968): Aminopyrine metabolism — enzyme activity in the day and night. J. Pharmacol Exp Ther. 163, 229.Google Scholar
  11. 11.
    Halberg F, Kabat H.F, Klein P. (1980): Am J. Hosp.: Pharm. 37 (Jan), 101–102Google Scholar
  12. 12.
    Belanger P. M. Lalande M, Labrecque G. and Dore F. (1985): Drug metab. Dispos. 18, 386.Google Scholar
  13. 13.
    Glynn J.P. and Kandel S. E. (1975): Paracetamol Measurement. Lancet (1); 1147–1158.CrossRefPubMedGoogle Scholar
  14. 14.
    Goodman and Gilman’s (1995): The Pharmacological Basis of Therapeutic. 9th Ed. International Ed. Pg. 1–25.Google Scholar
  15. 15.
    Yiamouyiannis C.A, Harris A. Sanders R. A. Martin B. J. Watkins J.B (1994): Paracetamol pharmacokinetics are independent of caloric intake and physical activity. Drug Invest. 8, 361–368.Google Scholar
  16. 16.
    Rumble R. H., Rebert M.S., Denton M.J. (1991): Effects of posture and sleep on the pharmacokinetics of acetaminophen and its major metabolites. Clin. Pharmacokinet. 20, (2); 167–173.CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2002

Authors and Affiliations

  • Kolawole J. A. 
    • 2
  • Chuhwak P. D. 
    • 2
  • Okeniyi S. O. 
    • 1
  1. 1.Department of ChemistryNDAKadunaNigeria
  2. 2.Dept. of Pharmaceutical Chemistry, Fac. of Pharmaceutical SciencesUniversity of JosJosNigeria

Personalised recommendations